Position in LLY
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$6,286,213
+$1,655,172 QoQ
Shares Held
5,241
+4.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.74%
of 13F equity value
Holder Rank
#1,544
of 4,605 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Joseph Group Capital Management holds $11,807,916 across 9 Drug Manufacturers - General names. LLY ranks #1 (53.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
5,241 | $6,286,213 | |
| 2 | AMGN |
Amgen Inc
|
14,086 | $5,100,822 | |
| 3 | JNJ |
Johnson & Johnson
|
589 | $149,588 | |
| 4 | ABBV |
AbbVie Inc.
|
421 | $105,940 | |
| 5 | MRK |
Merck & Co., Inc.
|
604 | $77,614 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
327 | $41,313 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
376 | $21,665 | |
| 8 | PFE |
Pfizer Inc
|
804 | $19,360 |
All Filings in LLY
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,286,213 | 5,241 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $4,631,041 | 5,035 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $5,323,965 | 4,954 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $4,330,025 | 5,675 | Shares | Sole | 2025-10-23 | |
| No filing history on record for this holder in this stock. | ||||||